Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Natera Inc
(NQ:
NTRA
)
122.40
+0.05 (+0.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Natera Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Evaluating Natera: Insights From 10 Financial Analysts
October 16, 2024
Via
Benzinga
Blue Skies, New Highs Remain Disciplined And Do Not Chase Extended Ideas
October 13, 2024
It is Fall clean up time. Sell lagging and sagging companies.
Via
Talk Markets
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
October 07, 2024
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Via
Chartmill
A Biotech Breakout Will Be Led By Small Caps
September 23, 2024
It’s hard to focus on biotech stocks right now because there are many distractions. The Fed and the rate cuts, AI and semiconductor stocks and geopolitical turmoil seemingly worse than ever.
Via
Talk Markets
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Court Orders Permanent Injunction Against NeoGenomics' Accused RaDaR Assay, as Case Enters New Phase
September 23, 2024
From
Natera, Inc.
Via
Business Wire
Analyst Scoreboard: 9 Ratings For Natera
September 13, 2024
Via
Benzinga
Peering Into Natera's Recent Short Interest
September 06, 2024
Via
Benzinga
Peeling Back The Layers: Exploring Natera Through Analyst Insights
August 27, 2024
Via
Benzinga
Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
September 16, 2024
A Relative Strength Rating upgrade for Tempus AI shows improving technical performance.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Natera Announces Three New Signatera Publications; Includes Groundbreaking Overall Survival Data Published in Nature Medicine and also Released at ESMO
September 16, 2024
From
Natera, Inc.
Via
Business Wire
First of its Kind Colorectal Cancer Data from Prospective GALAXY Study Released at ESMO; Demonstrates Signatera's Ability to Predict Overall Survival
September 14, 2024
From
Natera, Inc.
Via
Business Wire
Natera to Present New Signatera™ Colorectal Cancer Data at ESMO Showing 10X Advantage in Overall Survival
September 08, 2024
From
Natera, Inc.
Via
Business Wire
Forecasting The Future: 6 Analyst Projections For Natera
August 09, 2024
Via
Benzinga
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
August 20, 2024
The recent stock market dip provided some discounts.
Via
The Motley Fool
Shopify, Palantir And Uber Are Among Top 10 Large Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
August 11, 2024
Top 10 best performing large-cap stocks last week: Shopify, Palantir, Axon, Fortinet, Trade Desk, Natera, SharkNinja, Zillow, Aspen Tech, Uber.
Via
Benzinga
NTRA Stock Earnings: Natera Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
NTRA stock results show that Natera beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Natera Reports Second Quarter 2024 Financial Results
August 08, 2024
From
Natera, Inc.
Via
Business Wire
10 Health Care Stocks Whale Activity In Today's Session
August 08, 2024
Via
Benzinga
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
August 06, 2024
Via
Benzinga
(NTRA) - Analyzing Natera's Short Interest
July 23, 2024
Via
Benzinga
Natera to Participate in the Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Natera, Inc.
Via
Business Wire
Natera to Report its Second Quarter 2024 Results on August 8, 2024
July 30, 2024
From
Natera, Inc.
Via
Business Wire
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
July 26, 2024
From
Natera, Inc.
Via
Business Wire
Here's How Much You Would Have Made Owning Natera Stock In The Last 5 Years
July 18, 2024
Via
Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $4,300 Today
July 04, 2024
Via
Benzinga
$100 Invested In Natera 5 Years Ago Would Be Worth This Much Today
June 20, 2024
Via
Benzinga
The 3 Best Gene Editing Stocks to Buy in July 2024
July 08, 2024
Gene editing is revolutionizing medicine, creating substantial opportunities for some of the best gene editing stocks.
Via
InvestorPlace
Natera to Present at the 28th International Conference on Prenatal Diagnosis and Therapy
July 03, 2024
From
Natera, Inc.
Via
Business Wire
Trading SMID Biotech Stocks In A Volatile Market
July 01, 2024
Trading SMID biotech stocks is difficult no matter what you know. Large cap biopharma with dividends should be the focus for non-traders. Healthcare and smaller caps are lagging within the context of a...
Via
Talk Markets
Natera Announces DECIPHER: A Phase II, Single-Arm Adjuvant Trial in Gastroesophageal Cancer
June 27, 2024
From
Natera, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.